Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3011% above fair value
$9.01−0.03 (-0.33%)
Close on Nov 12, 2026Market cap $412.87MP/E 26.5Yield 0.44%
Core Laboratories ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Core Laboratories's ebitda for the twelve months ending Sep 30, 2026 was $53.92M, down 22.4% year over year. For fiscal 2025 it was $71.12M, down 3.3% from the year before. The highest annual figure on record is $73.51M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.12M | -3.3% |
| FY2024 | Dec 31, 2024 | $73.51M | +4.4% |
| FY2023 | Dec 31, 2023 | $70.42M | +20.0% |
| FY2022 | Dec 31, 2022 | $58.69M | -8.0% |
| FY2021 | Dec 31, 2021 | $63.78M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.79M | -35.6% |
| Q2 FY2026 | Jun 30, 2026 | $12.98M | -31.6% |
| Q1 FY2026 | Mar 31, 2026 | $5.65M | -30.5% |
| Q4 FY2025 | Dec 31, 2025 | $19.50M | +9.3% |
| Q3 FY2025 | Sep 30, 2025 | $24.52M | +4.4% |
| Q2 FY2025 | Jun 30, 2025 | $18.96M | -4.1% |
| Q1 FY2025 | Mar 31, 2025 | $8.13M | -34.5% |
| Q4 FY2024 | Dec 31, 2024 | $17.84M | -3.3% |
| Q3 FY2024 | Sep 30, 2024 | $23.48M | +26.2% |
| Q2 FY2024 | Jun 30, 2024 | $19.78M | -13.4% |
| Q1 FY2024 | Mar 31, 2024 | $12.41M | +17.9% |
| Q4 FY2023 | Dec 31, 2023 | $18.46M | -6.3% |
| Q3 FY2023 | Sep 30, 2023 | $18.60M | -1.1% |
| Q2 FY2023 | Jun 30, 2023 | $22.84M | +42.7% |
| Q1 FY2023 | Mar 31, 2023 | $10.53M | – |
| Q4 FY2022 | Dec 31, 2022 | $19.69M | – |
| Q3 FY2022 | Sep 30, 2022 | $18.82M | – |
| Q2 FY2022 | Jun 30, 2022 | $16.01M | – |
See a number that looks wrong?